ArticleCancer science2022

Inhibition of insulin-like growth factor-1 receptor enhances eribulin-induced DNA damage in colorectal cancer.

Tomoyasu Yoshihiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.